Early predictors of response to treatment in patients with chronic hepatitis C
- 1 January 1999
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 31, 237-243
- https://doi.org/10.1016/s0168-8278(99)80409-7
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort studyThe Lancet, 1998
- Determinants of outcome of compensated hepatitis C virus-related cirrhosisHepatology, 1998
- Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis CGastroenterology, 1997
- Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group.Gastroenterology, 1997
- Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C: Results of a multicenter randomized trialJournal of Hepatology, 1997
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Persistent Hepatitis C Viremia Predicts Late Relapse after Sustained Response to Interferon-α in Chronic Hepatitis CAnnals of Internal Medicine, 1996
- Serum HCV RNA titer at the end of interferon therapy predicts the long-term outcome of treatmentJournal of Hepatology, 1995
- Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CHepatology, 1995
- Interferon-α2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluationHepatology, 1993